Contact UsInvestorsCareersMediaScienceContact Us
Open Innovation

Great science means sharing knowledge and resources to work faster and achieve more.

HomeScienceOpen Innovation

Academic collaborations are a rich source of creativity and scientific talent. Pooling resources and expertise can help the UK life sciences community to find and develop new medicines and vaccines. It’s what we call our “R&D ecosystem”.

In 2023, we had 95 research collaborations and strategic alliances across the UK.1 Through these partnerships, we work with scientists, academics and clinicians to deliver world-leading science.

Collaboration with Cambridge University on an AI model to help predict chemical reaction outcomesIn 2019, we began a partnership with the University of Cambridge on an AI (artificial intelligence) driven project to help predict how certain chemicals will react with each other.Pfizer's collaboration with CMACWe've been a Tier 1 partner of the centre for Continuous Manufacturing and Advanced Crystallisation (CMAC), at the University of Strathclyde, since 2017.Innovative Target Exploration Network (ITEN)

An early-stage partnering model that fosters collaborative relationships with selected academic institutions in key hubs of scientific excellence. 

Partnership with Regeneron for UK Biobank Exome Sequencing

We are part of a collaboration that aims to speed up the exome sequencing of 500,000 UK participants. 

The Stratified Medicine Programme 

A collaborative initiative that aims to make a difference to patients with cancer through ‘precision’ medicine. 

INSPIRE Programme 

Our INSPIRE partnerships with NHS research networks are part of Pfizer’s international network of preferred sites for clinical research.

ADDoPT

In 2015 we joined ADDoPT, a 4 year £20.4 million collaborative project between government, pharmaceutical companies, SME's and academia.

Medical Research Council Collaboration

Between 2014 and 2018, Pfizer collaborated with the UK-based Medical Research Council to make available a ‘virtual library’ of compounds for use by academic researchers in the UK. 

References

  1. Pfizer data on file. April 2024.
PP-UNP-GBR-8513 / April 2024
Science Products Responsibility PartnershipsCareers Privacy Statement Terms of Use Contact UsSitemap Copyright © 2017-2024 Pfizer Limited. PP-UNP-GBR-8108 / January 2024. All rights reserved. Registered in England and Wales No. 526209. Registered office: Ramsgate Road, Sandwich, Kent CT13 9NJ. VAT No. GB201048427. This website is intended for the general public in the UK.